Emergent Biosolutions Inc

EBS 
(NYSE) 
 
$ 50,97 <%= Resources.Global.txtUp %>
Opdateret 23-05-2018
Ændring % 0,97% Stigning i aktiekurs
Ændring 0,49 Stigning i aktiekurs
Volume 29.024
Høj $ 51,30
Lav $ 50,42
Åben $ 50,42
ISIN
Seneste luk $ 50,48
# af aktier 49,82M
Markedsværdi 2.539,49M USD
I dag

Emergent Biosolutions Inc
Markedet er åbent (indtil 22:00) - Forsinket 15 min
 
Kursudvikling Seneste 1 uge 1 måned 3 mdr 6 mdr 1 år
 
  50,97 0,7% Stigning i aktiekurs -6,5% Fald i aktiekurs 5,8% Stigning i aktiekurs 22,3% Stigning i aktiekurs 68,4% Stigning i aktiekurs
Powered by TradingView

Nyheder om Emergent Biosolutions Inc

  • Dansk
  • Engelsk
  • Fondsbørsmeddelelser

Firmaprofil

Emergent BioSolutions Inc is a global biotechnology company that offers biopharmaceutical products to healthcare providers and governments. The company has two operating divisions: biodefense and biosciences. Its specialty biodefense division focuses on countermeasures that address public health threats. The U.S. government is the primary purchaser of these products and often provides substantial funding for their development. Emergent's biosciences business is primarily focused on hematology and oncology therapeutics, with a secondary focus on transplantation, infectious disease, and autoimmunity.

Copyright Euroinvestor A/S 2018  Disclaimer Cookie- og privatlivspolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
24. maj 2018 17:30:25
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20180515.2 - EUROWEB3 - 2018-05-24 17:30:25 - 2018-05-24 17:30:25 - 1 - Website: OKAY